AU2003226401A1 - Gelsolin as a prognostic marker of artherosclerotic diseases - Google Patents
Gelsolin as a prognostic marker of artherosclerotic diseasesInfo
- Publication number
- AU2003226401A1 AU2003226401A1 AU2003226401A AU2003226401A AU2003226401A1 AU 2003226401 A1 AU2003226401 A1 AU 2003226401A1 AU 2003226401 A AU2003226401 A AU 2003226401A AU 2003226401 A AU2003226401 A AU 2003226401A AU 2003226401 A1 AU2003226401 A1 AU 2003226401A1
- Authority
- AU
- Australia
- Prior art keywords
- gelsolin
- prognostic marker
- artherosclerotic
- diseases
- artherosclerotic diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/323—Arteriosclerosis, Stenosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37304302P | 2002-04-16 | 2002-04-16 | |
| US60/373,043 | 2002-04-16 | ||
| PCT/US2003/011722 WO2003088811A2 (en) | 2002-04-16 | 2003-04-16 | Gelsolin as a prognostic marker of artherosclerotic diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2003226401A1 true AU2003226401A1 (en) | 2003-11-03 |
| AU2003226401A8 AU2003226401A8 (en) | 2003-11-03 |
Family
ID=29250950
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003226401A Abandoned AU2003226401A1 (en) | 2002-04-16 | 2003-04-16 | Gelsolin as a prognostic marker of artherosclerotic diseases |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2003226401A1 (en) |
| WO (1) | WO2003088811A2 (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9408891B2 (en) | 2003-11-12 | 2016-08-09 | The Trustees Of The University Of Pennsylvania | Methods of using gelsolin to treat or prevent bacterial sepsis |
| DK1755661T3 (en) | 2004-05-12 | 2014-06-16 | Brigham & Womens Hospital | GELSOLIN FOR USE FOR TREATMENT OF INFECTIONS |
| CA2567223A1 (en) | 2004-05-19 | 2005-11-24 | Boehringer Ingelheim International Gmbh | Treatment of diseases associated with altered level of amyloid beta peptides |
| ES2651619T3 (en) | 2006-03-15 | 2018-01-29 | The Brigham And Women's Hospital, Inc. | Use of gelsolin to treat multiple sclerosis and diagnose neurological diseases |
| EP2001496B1 (en) | 2006-03-15 | 2017-05-31 | The Brigham And Women's Hospital, Inc. | Use of gelsolin to diagnose and treat inflammatory diseases |
| EP2708603B1 (en) | 2008-01-25 | 2017-04-19 | The General Hospital Corporation | Diagnostic and therapeutic uses of gelsolin in renal failure |
| AU2011319319B2 (en) * | 2010-10-20 | 2015-07-30 | Eisai R&D Management Co., Ltd. | Biomarker for Alzheimer's disease or mild cognitive impairment |
| EP2725360A1 (en) * | 2012-10-24 | 2014-04-30 | Fundació Hospital Universitari Vall d' Hebron - Institut de Recerca | Biomarkers for the prognosis of ischemic stroke |
| CN103242304A (en) * | 2013-05-21 | 2013-08-14 | 苏州科捷生物医药有限公司 | Synthetic method of anti-inflammatory drug tenidap sodium |
| CN107300589A (en) * | 2017-04-18 | 2017-10-27 | 广州仁恒医药科技股份有限公司 | A kind of chromatographic purity assay method of Difluprednate |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2080462C (en) * | 1990-04-11 | 2004-10-26 | Thomas P. Stossel | Therapeutic uses of actin-binding compounds |
-
2003
- 2003-04-16 AU AU2003226401A patent/AU2003226401A1/en not_active Abandoned
- 2003-04-16 WO PCT/US2003/011722 patent/WO2003088811A2/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003088811A2 (en) | 2003-10-30 |
| AU2003226401A8 (en) | 2003-11-03 |
| WO2003088811A3 (en) | 2004-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003288605A1 (en) | Providing presence information to an integrated presence system | |
| AU2003291630A1 (en) | Bluetooth transparent bridge | |
| AU2003210829A1 (en) | Battery-powered wristwatch | |
| AU2003264939A1 (en) | Watch | |
| AU2002326312A1 (en) | Cannabinoids | |
| AU2002329877A1 (en) | Cross reference to related art | |
| AU2003240756A1 (en) | World clock | |
| AU2002238814A1 (en) | Provision of location information | |
| AU2003256961A1 (en) | Tactile metronome | |
| AU2003253770A1 (en) | Dual well completion system | |
| AU2003281019A1 (en) | Method of mapping a three dimensional area | |
| AU2003268687A1 (en) | Novel salt of 2-acylaminothiazole derivative | |
| AU2003226401A1 (en) | Gelsolin as a prognostic marker of artherosclerotic diseases | |
| AU2003222197A1 (en) | Inhibition of rna function | |
| AU2002368511A1 (en) | Goniometric sensor | |
| AU2003214438A1 (en) | Providing location dependent information | |
| AU2003257167A1 (en) | Electrophysiology assay methods | |
| AU2003227904A1 (en) | Marker pens | |
| AUPS239302A0 (en) | Improvements to tow-bars | |
| AU2003282135A1 (en) | Transponder | |
| AU2003295800A1 (en) | Providing means to accrue miles or points | |
| AU2003270113A1 (en) | Isolated mapping point | |
| AU2003222988A1 (en) | Improvements relating to signal enhancement | |
| AU2003233286A1 (en) | Pth derivatives resistant to skin proteases | |
| AU2003254368A1 (en) | Coloured labels |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |